Regulation and expression of human Fabs under the control of the Escherichia coli arabinose promoter, P-BAD

被引:7
作者
Clark, MA
Hammond, FR
Papaioannou, A
Hawkins, NJ
Ward, RL
机构
[1] ST VINCENTS HOSP,DEPT MED ONCOL,DARLINGHURST,NSW 2010,AUSTRALIA
[2] UNIV NEW S WALES,SCH PATHOL,SYDNEY,NSW 2052,AUSTRALIA
[3] CRC,BIOPHARMACEUT RES,DARLINGHURST,NSW 2010,AUSTRALIA
来源
IMMUNOTECHNOLOGY | 1997年 / 3卷 / 03期
基金
英国医学研究理事会;
关键词
arabinose; promoter; Fabs;
D O I
10.1016/S1380-2933(97)00016-X
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: The L-arabinose operon from E. coli contains an inducible promoter P-BAD which has been extensively studied for the control of gene expression, P-BAD has a number of potential advantages over P-lac, and has been used successfully to promote high level expression of recombinant proteins. Objectives: The aim of this study was to investigate P-BAD as an alternative system to P-lac for the bacterial expression of recombinant Fabs, Study design: The promoter P-BAD from the E. coli arabinose operon araBAD and the gene encoding the regulator of this promoter, were cloned into the phagemid expression vector MCO1. Expression of human recombinant tetanus toroid (TT) and c-erbB2 Fabs under the control of P-BAD was compared at two induction temperatures with the same Fabs produced under the control of P-lac. Results: Expression of TT and c-erbB2 Fabs under the control of P-BAD was comparable to Fab expression from P-lac. However, highly expressed TT Fab under the control of P-BAD was localised to the soluble periplasmic fraction whereas under the control of P-lac, there was greater leakage of Fab into the culture supernatant. In addition, Fab expression from P-BAD could be more tightly repressed than from P-lac. Conclusion: P-BAD is a useful and cheaply inducible alternative to the more commonly used P-lac for the rapid expression of soluble recombinant human antibody fragments. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:217 / 226
页数:10
相关论文
共 36 条
[1]   SCREENING AND KINETIC-ANALYSIS OF RECOMBINANT ANTI-CEA ANTIBODY FRAGMENTS [J].
ABRAHAM, R ;
BUXBAUM, S ;
LINK, J ;
SMITH, R ;
VENTI, C ;
DARSLEY, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 183 (01) :119-125
[2]   ASSEMBLY OF COMBINATORIAL ANTIBODY LIBRARIES ON PHAGE SURFACES - THE GENE-III SITE [J].
BARBAS, CF ;
KANG, AS ;
LERNER, RA ;
BENKOVIC, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (18) :7978-7982
[3]   Expression of biologically active human SPARC in Escherichia coli [J].
Bassuk, JA ;
Baneyx, F ;
Vernon, RB ;
Funk, SE ;
Sage, EH .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 325 (01) :8-19
[4]   ESCHERICHIA-COLI SECRETION OF AN ACTIVE CHIMERIC ANTIBODY FRAGMENT [J].
BETTER, M ;
CHANG, CP ;
ROBINSON, RR ;
HORWITZ, AH .
SCIENCE, 1988, 240 (4855) :1041-1043
[5]   A NEW FAMILY OF SUGAR-INDUCIBLE EXPRESSION VECTORS FOR ESCHERICHIA-COLI [J].
CAGNON, C ;
VALVERDE, V ;
MASSON, JM .
PROTEIN ENGINEERING, 1991, 4 (07) :843-847
[6]   Isolation of human anti-c-erbB-2 Fabs from a lymph node-derived phage display library [J].
Clark, MA ;
Hawkins, NJ ;
Papaioannou, A ;
Fiddes, RJ ;
Ward, RL .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01) :166-174
[7]   A POINT MUTATION IN A MURINE IMMUNOGLOBULIN V-REGION STRONGLY INFLUENCES THE ANTIBODY YIELD IN ESCHERICHIA-COLI [J].
DUENAS, M ;
AYALA, M ;
VAZQUEZ, J ;
OHLIN, M ;
SODERLIND, E ;
BORREBAECK, CAK ;
GAVILONDO, JV .
GENE, 1995, 158 (01) :61-66
[8]   ISOLATION OF MONOCLONAL-ANTIBODIES SPECIFIC FOR HUMAN C-MYC PROTO-ONCOGENE PRODUCT [J].
EVAN, GI ;
LEWIS, GK ;
RAMSAY, G ;
BISHOP, JM .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (12) :3610-3616
[9]   HIGH-LEVEL EXPRESSION IN ESCHERICHIA-COLI OF THE GENE CODING FOR THE MAJOR STRUCTURAL PROTEIN (P72) OF AFRICAN SWINE FEVER VIRUS [J].
FREIJE, JMP ;
MUNOZ, M ;
VINEULA, E ;
LOPEZOTIN, C .
GENE, 1993, 123 (02) :259-262
[10]   TIGHT REGULATION, MODULATION, AND HIGH-LEVEL EXPRESSION BY VECTORS CONTAINING THE ARABINOSE P-BAD PROMOTER [J].
GUZMAN, LM ;
BELIN, D ;
CARSON, MJ ;
BECKWITH, J .
JOURNAL OF BACTERIOLOGY, 1995, 177 (14) :4121-4130